Immunological determinants of clinical outcome in Peruvian patients with tegumentary leishmaniasis treated with pentavalent antimonials

A Maurer-Cecchini, S Decuypere, F Chappuis, C Alexandrenne, S De Doncker, M Boelaert, JC Dujardin, L Loutan, JM Dayer, G Tulliano, J Arevalo, A Llanos-Cuentas, C Chizzolini

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Original languageEnglish
    JournalInfection and Immunity
    Issue number5
    Pages (from-to)2022-2029
    Number of pages8
    Publication statusPublished - 2009


    • B780-tropical-medicine
    • Protozoal diseases
    • Leishmaniasis
    • Tegumentary
    • Drug therapy
    • Antimonials
    • Treatment outcomes
    • Immune response
    • mRNA
    • Interferon-gamma
    • Tumor necrosis factor alpha
    • Interleukin-10
    • Interleukin-4
    • Interleukin-13
    • T-cells
    • Macrophages
    • Peru
    • America-Latin

    Cite this